drugset / Trial / NCT00409435
A Study of Pyridostigmine in Postural Tachycardia Syndrome
Phase 2
Recruiting
50 enrolled
Mayo Clinic
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to improve tachycardia and stabilize blood pressure.
Timeline
- Start
- 2006-10
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pyridostigmine | Small molecule | 180 mg | — |